322 related articles for article (PubMed ID: 17097377)
1. Rituximab for the treatment of the skin manifestations of dermatomyositis: a report of 3 cases.
Dinh HV; McCormack C; Hall S; Prince HM
J Am Acad Dermatol; 2007 Jan; 56(1):148-53. PubMed ID: 17097377
[TBL] [Abstract][Full Text] [Related]
2. Therapy of refractory pemphigus vulgaris with monoclonal anti-CD20 antibody (rituximab).
Morrison LH
J Am Acad Dermatol; 2004 Nov; 51(5):817-9. PubMed ID: 15523367
[TBL] [Abstract][Full Text] [Related]
3. Anti-CD20 monoclonal antibody (rituximab) in the treatment of pemphigus.
Arin MJ; Engert A; Krieg T; Hunzelmann N
Br J Dermatol; 2005 Sep; 153(3):620-5. PubMed ID: 16120153
[TBL] [Abstract][Full Text] [Related]
4. Two courses of rituximab (anti-CD20 monoclonal antibody) for recalcitrant pemphigus vulgaris.
Faurschou A; Gniadecki R
Int J Dermatol; 2008 Mar; 47(3):292-4. PubMed ID: 18289336
[TBL] [Abstract][Full Text] [Related]
5. Topical FK506 (tacrolimus) therapy for facial erythematous lesions of cutaneous lupus erythematosus and dermatomyositis.
Yoshimasu T; Ohtani T; Sakamoto T; Oshima A; Furukawa F
Eur J Dermatol; 2002; 12(1):50-2. PubMed ID: 11809595
[TBL] [Abstract][Full Text] [Related]
6. Rituximab in the treatment of dermatomyositis: an open-label pilot study.
Levine TD
Arthritis Rheum; 2005 Feb; 52(2):601-7. PubMed ID: 15692974
[TBL] [Abstract][Full Text] [Related]
7. Rituximab as therapy for refractory polymyositis and dermatomyositis.
Noss EH; Hausner-Sypek DL; Weinblatt ME
J Rheumatol; 2006 May; 33(5):1021-6. PubMed ID: 16541475
[TBL] [Abstract][Full Text] [Related]
8. A pilot trial of rituximab in the treatment of patients with dermatomyositis.
Chung L; Genovese MC; Fiorentino DF
Arch Dermatol; 2007 Jun; 143(6):763-7. PubMed ID: 17576943
[TBL] [Abstract][Full Text] [Related]
9. Systemic immunomodulatory therapy in severe dry eye secondary to inflammation.
Cordero-Coma M; Anzaar F; Sobrin L; Foster CS
Ocul Immunol Inflamm; 2007; 15(2):99-104. PubMed ID: 17558834
[TBL] [Abstract][Full Text] [Related]
10. Rituximab for the treatment of juvenile dermatomyositis: a report of four pediatric patients.
Cooper MA; Willingham DL; Brown DE; French AR; Shih FF; White AJ
Arthritis Rheum; 2007 Sep; 56(9):3107-11. PubMed ID: 17763414
[TBL] [Abstract][Full Text] [Related]
11. A case of refractory vasculitic ulcers in a systemic lupus erythematosus patient responding to rituximab and hyperbaric oxygen therapy.
Lui NL; Thumboo J; Fong KY
Int J Rheum Dis; 2009 Dec; 12(4):366-9. PubMed ID: 20374378
[TBL] [Abstract][Full Text] [Related]
12. Rituximab in refractory pemphigus vulgaris.
Sorce M; Aricò M; Bongiorno MR
Dermatol Ther; 2008 Jul; 21 Suppl 1():S6-9. PubMed ID: 18727815
[TBL] [Abstract][Full Text] [Related]
13. Anti-CD20 monoclonal antibody in acute life threatening haemolytic anaemia complicating childhood onset SLE.
Abdwani R; Mani R
Lupus; 2009 Apr; 18(5):460-4. PubMed ID: 19318402
[TBL] [Abstract][Full Text] [Related]
14. Successful treatment of refractory skin manifestations of systemic lupus erythematosus with rituximab: report of a case.
Uthman I; Taher A; Abbas O; Menassa J; Ghosn S
Dermatology; 2008; 216(3):257-9. PubMed ID: 18182821
[No Abstract] [Full Text] [Related]
15. [Refractory dermatomyositis associated with chronic organizing pneumonia treated with rituximab: report of one case].
Yáñez V J; Cisternas M M; Saldías H V; Saldías P F
Rev Med Chil; 2009 Jan; 137(1):88-93. PubMed ID: 19399327
[TBL] [Abstract][Full Text] [Related]
16. Variability in the biological response to anti-CD20 B cell depletion in systemic lupus erythaematosus.
Albert D; Dunham J; Khan S; Stansberry J; Kolasinski S; Tsai D; Pullman-Mooar S; Barnack F; Striebich C; Looney RJ; Prak ET; Kimberly R; Zhang Y; Eisenberg R
Ann Rheum Dis; 2008 Dec; 67(12):1724-31. PubMed ID: 18250115
[TBL] [Abstract][Full Text] [Related]
17. Experiences and problems pre-operative anti-CD20 monoclonal antibody infusion therapy with splenectomy and plasma exchange for ABO-incompatible living-donor liver transplantation.
Usui M; Isaji S; Mizuno S; Sakurai H; Uemoto S
Clin Transplant; 2007; 21(1):24-31. PubMed ID: 17302588
[TBL] [Abstract][Full Text] [Related]
18. Disseminated Nocardia brasiliensis infection: an unusual complication of immunosuppressive treatment for childhood dermatomyositis.
Klein-Gitelman MS; Szer IS
J Rheumatol; 1991 Aug; 18(8):1243-6. PubMed ID: 1941833
[TBL] [Abstract][Full Text] [Related]
19. A primer of collagen disease.
Tuffanelli DL
Minn Med; 1974 Oct; 57(10):798-808, 820. PubMed ID: 4608343
[No Abstract] [Full Text] [Related]
20. Combination antimalarials in the treatment of cutaneous dermatomyositis: a retrospective study.
Ang GC; Werth VP
Arch Dermatol; 2005 Jul; 141(7):855-9. PubMed ID: 16027300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
